Sickle cell disease: Registry of the Spanish Society of Pediatric Hematology;Enfermedad de células falciformes: Registro de la Sociedad Española de Hematología Pediátrica

Anales de Pediatria

Volumn 64, Issue 1, 2006, Pages 78-84

  Garcia Arias M B ^a,b   Cantalejo Lopez M A ^b   Cela De Julian M E ^b   Bravo Clouzet, R ^c   Galaron Garcia P ^b   Belendez Bieler C ^b  

^a Centre de Salud Cerro Almodóvar   (Spain)

^b HOSPITAL MATERNO INFANTIL GREGORIO MARAÑÓN   (Spain)

^c Instituto Oncológico del Oriente Boliviano   (Bolivia)

Author keywords

Children; Epidemiology; Medical record; Sickle cell disease

Indexed keywords

HYDROXYUREA;

AFRICA; ARTICLE; BILIARY TRACT DISEASE; BODY HEIGHT; CHILD; CHILDHOOD DISEASE; CLINICAL TRIAL; FEMALE; FOLLOW UP; GENETIC DISORDER; HEMATOLOGY; HOSPITALIZATION; HUMAN; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEUROPHYSIOLOGY; REGISTER; SICKLE CELL ANEMIA; SPAIN; STATISTICAL SIGNIFICANCE; STEM CELL TRANSPLANTATION; SYMPTOMATOLOGY; TREATMENT OUTCOME; WEIGHT GAIN;

EID: 33644526968     PISSN: 16954033     EISSN: None     Source Type: Journal    
DOI: 10.1157/13083837     Document Type: Article

References (26)

1. Nagel RL, Fleming AF. Genetic epidemiology of the beta s gene. Baillieres Clin Haematol. 1992;5:331-65.
2. Bunn HF, Forget BF, Ranney HM. Hemoglobinopathies. Major Probl Intern Med. 1977;12:1-291.
3. Aidoo M, Terlouw DJ, Kolozak MS, McElroy PD, O ter Kulle F, Kariuki S, et al. Pretective effects of the sickle cell gene against malaria morbidity and mortality. Lancet. 2002;359: 1311-2.
4. Diallo D, Tchernia G. Sickle cell disease in Africa. Curr Opin Hematol. 2002;9:111-6.
5. Moormann AM, Embury PE, Opondo J, Sumba OP, Ouama JH, Kazura JW, et al. Frequencies of sickle cell trait and glucose-6-phosphate dehydrogenase deficiency differ in highland and nearby lowland malaria-endemic areas of Kenya. Trans R Soc Trop Med Hyg. 2003;97:513-4.
6. Segbena AY, Kueviakoe I, Messie AK, Napo-Koura IG, Vovor A, David M. Hemoglobin anomalies at the university hospital center in Lome, Togo. Med Trop (Mars). 2002;62:51-4.
7. Djembo-Taty M, Tchiloemba M, Galacteros F, Rosa J, Lissouba P. Epidemiologic study of hemoglobinopathies in the Congo in 2257 newborn infants. Nouv Rev Fr Hematol. 1986;28:249-51.
8. Wurie AT, Wurie IM, Gevao SM, Robbin-Coker DJ. The prevalence of sickle cell trait in Sierra Leone. A laboratory profile. West Afr J Med. 1996;15:201-3.
9. Thiriet P, Lobe MM, Gweha I, Gozal D. Prevalence of the sickle cell trait in an athletic West African population. Med Sci Sports Exerc. 1991;23;389-90.
10. Deyde VM, Lo BB, Khalifa IO, Ly B, Ball A, Fattoum S. Epidemiological profile of hemoglobinopathies in the Mauritanian population. Ann Hematol. 2002;81:320-1.
11. Baysal E. Hemoglobinopathies in the United Arab Emirates. Hemoglobin. 2001;25:247-53.
12. Ashley-Koch A, Yang Q, Olney RS. Sickle Hemoglobin (HbS) Allele and Sickle Cell Disease: A HuGE Review. Am J Epidemiol. 2000;151:839-45.
13. Mohanty D, Mukherjee MB. Sickle cell disease in India. Curr Opin Hematol. 2002;9:117-22.
14. Frikha M, Fakhfakh F, Mseddi S, Gargouri J, Ghali L, Labiadh Z, et al. Hemoglobin beta S haplotype in the Kebili region (southern Tunisia). Transfus Clin Biol. 1998;5:166-72.
15. McMahon C, Callaghan CO, O'Brien D, Smith OP. The increasing prevalence of childhood sickle-cell disease in Ireland. Ir J Med Sci. 2001;170:183-5.
16. Graesdal JS, Gundersen K, Holm B, Waage A. Thalassemia and sickle-cell disease in Norway. Tidsskr Nor Laegeforen. 2001; 121:678-80.
17. Neonato MG, Guilloud-Bataille M, Beauvais P, Begue P, Belloy M, Benkerrou M, et al. Acute clinical events in 299 homozygous sickle cell patients living in France. French Study Group on Sickle Cell Disease. Eur J Haematol. 2000;65:155-64.
18. Hickman M, Modell B, Greengross P, Chapman C, Layton M, Falconer S, et al. Mapping the prevalence of sickle cell and beta thalassaemia in England: Estimating and validating ethnic-specific rates. Br J Haematol. 1999;104:860-7.
19. Aluoch JR, De Geus A, Goudsmit R. Clinical and laboratory features of sickle cell disease in The Netherlands. Trop Geogr Med. 1998;40:7-12.
20. Kar BC. Sickle cell disease in India. J Assoc Physicians India. 1991;39:954-60.
21. De Montalembert M, Guilloud-Bataille M, Feingold J, Girot R. Epidemiological and clinical study of sickle cell disease in France, French Guinea and Algeria. Eur J Haematol. 1993;51: 136-40.
22. Dompier C, Setty BN, Eggleston B, Brodecki D, O'neal P, Stuart M. Vaso-Occlusion in Children With Sickle Cell Disease: Clinical Characteristics and Biologic Correlates. J Pediatr Hematol Oncol. 2004;26:785-90.
23. Wierenga KJJ, Hambleton IR, Wilson RM, Alexander H, Serjeant BE, Serjeant GR. Significance of fever in Jamaican patients with homozygous sickle cell disease. Arch Dis Child. 2001;84: 156-9.
24. Gill FM, Sleeper LA, Weiner SJ, Brown AK, Bellevue R, Grover R, et al. Clinical events in the first decade in a cohort of infants with sickle cell disease. Cooperative study of sickle cell disease. Blood. 1995;86:776-83.
25. Solanki DL, Kletter GG, Castro O. Acute splenic sequestration crises in adults with sickle cell disease. Am J Med. 1986;80: 985-90.
26. Emond AM, Collins R, Darvill D, Higgs DR, Maude GH, Serjeant GR. Acute splenic sequestration in homozygous sickle cell disease: Natural history and management. J Pediatr. 1985; 107:201-6.